Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.

Détails

ID Serval
serval:BIB_88CF065FE0CA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.
Périodique
Preventive medicine
Auteur⸱e⸱s
Puricelli Perin D.M., Elfström K.M., Bulliard J.L., Burón A., Campbell C., Flugelman A.A., Giordano L., Kamineni A., Ponti A., Rabeneck L., Saraiya M., Smith R.A., Broeders MJM
Collaborateur⸱rice⸱s
International Cancer Screening Network
ISSN
1096-0260 (Electronic)
ISSN-L
0091-7435
Statut éditorial
Publié
Date de publication
10/2021
Peer-reviewed
Oui
Volume
151
Pages
106642
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural
Publication Status: ppublish
Résumé
Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that led to cancer screening suspension. Information about communication, impact on resources, and patient follow-up was collected. Quantitative data was analyzed as frequencies overall and by setting, while a comment section under each survey item captured nuanced details. Responses were recategorized into 66 settings, representing 35 countries. Most settings suspended cancer screening services (n = 60, 90.9%) in March 2020 (n = 45, 68.2%), guided by a government decision (n = 51, 77.3%). Few settings made the decision whether to suspend services based on a preparedness plan (n = 17, 25.8%). In most settings, professionals were reassigned (n = 41, 62.1%) and infrastructure repurposed (n = 35, 53.0%). The first wave of the COVID-19 pandemic has had profound effects on cancer screening worldwide, including the suspension of services in almost all settings. Most settings were unprepared to deal with the scale of the pandemic but demonstrated flexibility in the response. These results contribute to inform, through experiences and lessons learned, the next steps for the global cancer screening community to further evaluate the impact of COVID-19 and prepare for future disruptions.
Mots-clé
COVID-19, Early Detection of Cancer, Humans, Neoplasms/diagnosis, Pandemics, SARS-CoV-2, Surveys and Questionnaires, Cancer screening, Disruption, Health care services
Pubmed
Web of science
Création de la notice
09/07/2021 16:57
Dernière modification de la notice
25/02/2022 6:37
Données d'usage